688317 之江生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额16,281(81,885)584,971641,9371,141,796
投资活动产生之现金流量净额(13,028)(77,689)(76,021)(519,061)(86,303)
筹资活动产生之现金流量净额(13,444)(234,393)(371,404)1,628,003(68,505)
汇率变动对现金及现金等价物的影响1,21015,77374,354(19,816)(28,352)
现金及现金等价物净增加/(减少)(8,980)(378,194)211,9001,731,063958,637
期初现金及现金等价物余额2,769,4953,147,4762,935,5751,204,512245,876
期末现金及现金等价物余额2,760,5152,769,2823,147,4762,935,5751,204,512